Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance

• J. Stuart Ferriss,

  Affiliation Department of Obstetrics, Gynecology and Reproductive Sciences, Temple University, Philadelphia, Pennsylvania, United States of America

  ⨯
• Youngchul Kim,

  Affiliation Division of Biostatistics and Epidemiology, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Linda Duska,

  Affiliation Thornton Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Michael Birrer,

  Affiliation Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Douglas A. Levine,

  Affiliation Gynecology Service and Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Christopher Moskaluk,

  Affiliation Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯
• Dan Theodorescu,

  Affiliation Department of Surgery and Pharmacology, University of Colorado at Denver, Aurora, Colorado, United States of America

  ⨯
• Jae K. Lee

  * E-mail: jkl7n@virginia.edu

  Affiliation Division of Biostatistics and Epidemiology, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, United States of America

  ⨯